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ABSTRACT
Introduction: Rupture of an abdominal aortic
aneurysm (rAAA) carries a considerable mortality rate
and is often fatal. rAAA can be treated through open or
endovascular surgical intervention and it is possible
that more rapid access to definitive intervention might
be a key aspect of improving mortality for rAAA.
Diagnosis is not always straightforward with up to
42% of rAAA initially misdiagnosed, introducing
potentially harmful delay. There is a need for an
effective clinical decision support tool for accurate
prehospital diagnosis and triage to enable transfer to
an appropriate centre.
Methods and analysis: Prospective multicentre
observational study assessing the diagnostic accuracy of
a prehospital smartphone triage tool for detection of
rAAA. The study will be conducted across London in
conjunction with London Ambulance Service (LAS).
A logistic score predicting the risk of rAAA by assessing
ten key parameters was developed and retrospectively
validated through logistic regression analysis of
ambulance records and Hospital Episode Statistics data
for 2200 patients from 2005 to 2010. The triage tool is
integrated into a secure mobile app for major smartphone
platforms. Key parameters collected from the app will be
retrospectively matched with final hospital discharge
diagnosis for each patient encounter. The primary
outcome is to assess the sensitivity, specificity and
positive predictive value of the rAAA triage tool logistic
score in prospective use as a mob app for prehospital
ambulance clinicians. Data collection started in
November 2014 and the study will recruit a minimum of
1150 non-consecutive patients over a time period of
2 years.
Ethics and dissemination: Full ethical approval has
been gained for this study. The results of this study will
be disseminated in peer-reviewed publications, and
international/national presentations.
Trial registration number: CPMS 16459; pre-results.
BACKGROUND
Abdominal aortic aneurysms (AAAs) are a
signiﬁcant health problem that account for 4
deaths per 100 000 population per year.1
Rupture of an abdominal aortic aneurysm
(rAAA) carries a high mortality rate and is
often fatal.2 3 Although rare cases survive con-
servative management following ‘contained
rupture’, survival from rAAA is generally only
possible with deﬁnitive surgery, which can be
either open repair or endovascular surgical
intervention (EVAR). For patients with rAAA,
many non-operative factors are key determi-
nants of survival.4 The lowest mortality for
rAAA is seen in hospitals that have greater
bed capacities, greater availability of support
services, higher annual procedural caseload
of AAA repair with a greater proportion of
cases undergoing endovascular repair.4 Data
from a large prospective multicentre rando-
mised clinical trial of different surgical tech-
niques (IMPROVE) suggests that the type of
surgery itself may not play as great a role in
overall survival.2 5 6 In-hospital survival from
rAAA, intervention rates and uptake of endo-
vascular repair are lower in England than in
Strengths and limitations of this study
▪ Prospective multicentre observational study
across major city.
▪ Large number of patient cases in target
population.
▪ Use of mobile technology to facilitate accurate
data collection.
▪ Assessment and validation of clinical decision-
making tool for prehospital diagnosis of ruptured
abdominal aortic aneurysm.
▪ Potential for non-random patient selection and
confounding introducing bias.
▪ Reliant on accurate documentation of final
hospital discharge diagnosis for each patient
encounter.
▪ Incomplete data entry sets are not saved.
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the USA, further suggesting there is room for improve-
ment in the organisation and delivery of care.
It is possible that more rapid access to specialist care
might improve mortality for rAAA, though selection of
the ﬁttest patients for transfer precludes deﬁnitive evi-
dence to support this likelihood.7–11 Currently in
London, patients are taken to the nearest hospital
regardless of its ability to provide repair for rAAA,12 and
protocols for triage of suspected rAAA are not routine
across the UK. Diagnosis is not always straightforward
with up to 42% of rAAA initially misdiagnosed, introdu-
cing potentially harmful delay when patients require
interhospital transfer.13 The signs and symptoms of
rAAA may be unreliable and patients frequently show
additional features that may confound the diagnosis.14
There is a need for an effective clinical decision support
tool for accurate prehospital diagnosis and triage to
enable transfer to an appropriate centre. Such triage
systems are already in place for patients with suspected
stroke, ST elevation myocardial infarction (STEMI) and
major trauma which have all been shown to be effective
in reducing morbidity and mortality.15–17 In London,
patients with suspected rAAA are currently taken to the
nearest hospital for further assessment, regardless of its
capability to repair rAAA. This can introduce additional
delays for patients who subsequently require transfer to
a vascular service, which in turn might increase morta-
lity. It is possible that rapid more accurate diagnostic
assessment in the prehospital environment and direct
transfer to a vascular centre capable of providing deﬁni-
tive intervention might permit reduced mortality for
populations with rAAA. However, there are currently no
clinical triage tools to act as decision aids for prehospital
service providers to estimate the risk of rAAA diagnosis
based on presenting symptoms and medical assessment.
If rAAA could be more accurately diagnosed in the pre-
hospital setting, there is potential that more patients
might receive deﬁnitive care. Any such tool should be
accurate and feasible for use in the prehospital setting.
FILTR is a pilot prospective multicentre observational
study, assessing the diagnostic accuracy of an ambulance
smartphone triage tool for detection of rAAA. The ﬁrst
stage in developing a prehospital triage system requires vali-
dation and assessment of a clinical decision support system.
This will be conducted across London in conjunction with
London Ambulance Service (LAS). LAS clinicians will use
a logistic score developed at St George’s Vascular Institute
for use as a mobile app on a smartphone platform. During
each patient encounter, key parameters required to predict
risk of rAAAwill be collected using the app. Final discharge
diagnosis will be retrospectively identiﬁed and collated for
each encounter. This will enable assessment of the feasibil-
ity, validity and safety of the prehospital smartphone triage
tool for rAAA. Secondary analysis will also allow modelling
of the implications of such an approach for ‘false positive’
patients with other differential diagnoses if transferred to a
vascular centre, or the implications of such an approach for
service conﬁguration and workload.
METHODS
Trial design and objectives
FILTR is a prospective multicentre observational study
assessing the diagnostic accuracy of an ambulance smart-
phone triage tool for detection of rAAA for 2 years. The
objective of FILTR is to assess whether a logistic score
hosted on a smartphone app can be feasible and accu-
rate for diagnosis of rAAA at the scene of an emergency.
Ethical approval and dissemination
Full ethical approval has been gained from the NRES
Committee North West, reference 14/NW/0123. Further
consultation and approval has been obtained from the
NHS Health Research Authority Conﬁdentiality Advisory
Group, reference: 15/CAG/0152. The results of this
study will be disseminated in peer-reviewed publications
and international/national presentations.
Funding
FILTR is supported by an Academy of Medical Sciences
Clinical Lecturer Starter Grant awarded to author AK. It
is also supported by grants from the Laerdal Foundation
and South West London Academic Health and Social
Care System.
Registration
This is a portfolio study with UK Clinical Research
Network Study Portfolio no. UKCRN ID 16459.
Inclusion criteria
All patients over the age of 18 years assessed by a LAS
clinician with acute abdominal/back/chest pain or col-
lapse requiring transfer to hospital who do not fulﬁl
entry criteria for existing triage tools such as myocardial
infarction (MI), stroke and major trauma during the
recruitment period will be eligible for inclusion.
Exclusion criteria
The exclusion criteria are:
1. Any patient under the age of 18 years
2. Any patient not requiring transfer to hospital
3. Any patient with conﬁrmed or suspected acute myo-
cardial infarction (MI), major trauma or stroke as
existing triage tools already exist for this condition
Smartphone triage tool
St George’s Vascular Institute and the London
Ambulance Service have developed a scoring system to
diagnose rAAA based on ten key parameters. The score
was developed with logistic regression of ambulance
records and Hospital Episode Statistics (HES) data for
2200 patients from 2005 to 2010. The score used routine
ambulance clinician assessments and detected rAAA
with 82.6% sensitivity (area under the receiver operating
characteristic (ROC) curve 0.86). The parameters col-
lected by the app are: age, gender, blood pressure, capil-
lary reﬁll time, temperature, and history of collapse,
back pain, diabetes, cancer or peripheral vascular
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disease. This triage tool has been integrated into a
secure mobile app available for smartphones on all
major operating systems. This mobile app has been
made available to all LAS clinicians for the observational
study since November 2014. LAS clinicians, including
paramedics, paramedic students and technicians, will
download the app onto their own personal smartphone.
A website was set up to coordinate educational meetings
and provide regular study updates.18 LAS clinicians are
advised to enter physiological parameter data as soon as
it is safe to do so from a clinical perspective using the
ﬁrst available set of observations, and in the same cir-
cumstances as completing existing patient report forms
(PRFs). Pilot results show that data entry takes an
average (mean) of 16 s per patient. There will be no
change to the underlying logistic regression model
during the course of the study, and no intention to
update or modify the app thereby preventing issues with
version control. The app design prevents the saving of
incomplete data entry at the point of care. Incomplete
patient records will be included in the analysis, where
possible as per the Strengthening the Reporting of
Observational Studies in Epidemiology (STROBE)
guidelines. There is the possibility for incomplete data
in terms of diagnosis retrieval, outcome (mortality)
retrieval and discordance between the PRF data and the
app data. Owing to the study design, we will not be able
to follow-up eligible patients whose data are not origin-
ally included in the app. This should not prove a limita-
tion of the study as the aim of the study is to assess the
sensitivity and speciﬁcity of the model for prediction of
rAAA. Assessment of any incomplete data entries will
provide an outcome measure regarding potential app
user error rate. This will include a sensitivity analysis
whereby the ROC curve for mortality and rAAA diagno-
sis using each combination of ‘app data’, ‘PRF data’ and
‘app/PRF concordant data’ will be produced.
Primary outcome
1. To assess and validate the sensitivity and speciﬁcity of
the rAAA smartphone triage tool
Secondary outcomes
1. To assess feasibility and safety of a mobile app-based
clinical decision support system delivered at the point
of care in a pre-hospital setting. This includes cost-
effectiveness, research effectiveness, paramedic satis-
faction and overall utility.
2. To model the ﬁnancial effect and workload for LAS,
emergency departments and tertiary vascular centres
if the destination of a patient with suspected rAAA
was determined by the smartphone triage tool, for
example, the extra distance/time required for the
ambulance to travel to a specialist hospital; or the
modelled outcomes of care for ‘false positive’
patients without rAAA transferred for care at a vascu-
lar centre.
Power calculation
Modelling from HES data covering the period 2005–
2010 estimates that over a 12-month period 150 rAAA
and over 1000 controls (ie, patients found not to have a
rAAA) will be studied. The study will recruit a minimum
of 1150 non-consecutive patients. Expected CIs asso-
ciated with predicted model performance are as follows:
83% sensitivity (95% CI 75.9% to 88.2%); 73% speciﬁ-
city (95% CI 69.0% to 78.3%). The expected ROC curve
characteristic will have an area under the curve statistic
of 0.85±0.01.
Statistical analysis
True positive and true negative diagnoses will be deﬁned
according to the hospital discharge record retrieved by
site investigators at each participating hospital.
Contingency table analysis will allow reporting of sensi-
tivity, speciﬁcity, positive predictive and negative predict-
ive rates for the logistic score, with CIs determined by
sample size. The development and validation data sets
will be further explored for model reﬁnement using a
logistic regression approach, with the same entry vari-
ables entered into forward selection, removal from
models at p<0.1, and signiﬁcance ascribed at p<0.05. An
ROC curve will be reported for rAAA diagnosis using
the original logistic score, and the reﬁned score at the
study end. Separate logistic models will be designed to
explore 30-day mortality. Where diagnosis or mortality
data cannot be retrieved, ROC analysis is impossible. As
per STROBE guidelines, this study will fully describe the
available data for patients with diagnoses/mortality and
those without diagnosis/mortality, and subject the demo-
graphics/presenting features of both cohorts to statis-
tical comparison to explore whether the absence of
diagnosis data has introduced selection bias to the study.
Patient pathway
The patient pathway and data collection is outlined in
ﬁgure 1. The data collection process uses a pre-existing
service evaluation framework currently in use by LAS to
identify in-hospital discharge diagnosis for patients using
their service. At no point does this study alter patient
triage, treatment or destination. A secure website was set
up to collect and store the logistic score from the app.
Informed consent
LAS clinicians, in line with General Medical Council
(GMC) guidance regarding consent in emergencies, will
not need to seek formal consent from patients in order
to enrol them in this observational study. This is deter-
mined on the basis that patients with suspected rAAA
may be in extremis and therefore treatment provided is
immediately necessary to ‘save their life to prevent seri-
ous deterioration of their condition’ (GMC Guidance on
Consent). This has been discussed with the NHS Health
Research Authority, who agree that this is appropriate
given the nature of the study. No patient-identiﬁable
Lewis TL, et al. BMJ Open 2016;6:e011308. doi:10.1136/bmjopen-2016-011308 3
Open Access
data are collected during the course of medical assess-
ment and transfer to deﬁnitive care.
Treatment and follow-up
This observational study will have no impact on triage,
treatment or follow-up for the patients involved.
DISCUSSION
In-hospital mortality for rAAA who survive to the point
of hospital admission is estimated to be 65.9% for
England,19 with lower mortality achieved in the group
selected for operative management, where 1-year morta-
lity is 38.6% following EVAR and 42.8% following open
repair.3 There remains ongoing uncertainty regarding
how to reduce mortality with many non-operative factors
being key determinants of survival. Current recommen-
dations suggest that reductions in mortality might be
achieved by rapid direct transfer to a high-volume spe-
cialist centre, that offers ready availability of the full
spectrum of endovascular and open surgical care, with
appropriate support facility and intensive care. This is at
odds with existing prehospital service provision for
patients with suspected rAAA, who are usually taken to
the nearest hospital, often requiring secondary interhos-
pital transfer for deﬁnitive care. Prehospital triage
systems have been shown to be successful for other con-
ditions such as major trauma, STEMI and stroke, and
there are possibly signiﬁcant implications if a similar
system could be implemented for rAAA.15–17 Challenges
for such an approach will include the diagnostic accur-
acy with which rAAA can be triaged at the scene of the
emergency, and also the fate of patients incorrectly diag-
nosed with rAAA and nonetheless subjected to
prolonged transfer and management at a vascular
centre. Finally, outcomes in patients with rAAA that were
not identiﬁed will also require investigation and
estimation.
Given this study links prehospital and hospital care, an
extensive collaborative approach has been employed to
the beneﬁt of the study design and patient pathway. In
order to be pragmatic, existing information pathways for
data collection have been used and the smartphone app
records only routinely collected data. At no point does
this study alter patient triage, treatment or destination,
but it may provide support for an efﬁcacy study of ﬁeld
triage in the future.
This prospective validation study uses an observational
approach to test the diagnostic accuracy of a smartphone
triage tool to support clinical decision-making for the diag-
nosis of rAAA at the scene of the emergency. We anticipate
that assessment and validation of the smartphone triage
tool will provide feasibility evidence for the use of smart-
phones in the emergency setting and their use in a pro-
spective observational study; as well as provide data for
whether such an approach could be beneﬁcial to patients
with rAAA without unacceptable consequences for the
wider population with differential diagnoses suspected to
be rAAA. The study is potentially limited by geographical
issues, such as generalisability beyond London to less urban
healthcare settings. It will not be possible to collect data for
patients eligible but not recruited in FILTR, and the reli-
ability with which paramedics use each aspect of the app
will not be monitored prospectively, though retrospective
audit will be performed between LAS paper records and
electronic FILTR records for each included patient. It is not
possible to identify which data ﬁelds are most difﬁcult to
enter due to the app not saving incomplete data entry sets.
Figure 1 Flow diagram indicating patient and data pathway for FILTR prospective multicentre observational study. CAD,
computer-aided dispatch log; DOB, date of birth; LAS, London Ambulance Service.
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Status
The study started recruitment in November 2014 and
will close recruitment in November 2016.
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